Canaan Partners
http://www.canaan.com/homeCanaan Partners is a venture capital firm that invests in early stage technology and healthcare companies. Since its founding in 1987, Canaan has invested in more than 250 companies including DoubleClick and Match.com.
View Older Stories View More Recent Stories
-
Positive Pre-Clinical Data Supporting SPX-101 to be Presented at the North American Cystic Fibrosis Conference
-
CircleUp Announces CircleUp Growth Partners, a New $125 Million Fund
-
A.I. Company Founded by Google’s Youngest Employee Partners with Former FBI Hostage Negotiator to Revolutionize Dealmaking
-
Clinical Data from Phase 1 PK/PD Study of Octreotide for Intranasal Delivery to be Presented at North American Neuroendocrine Tumor Society Symposium
-
Spyryx Biosciences Announces First Patient Enrolled in Phase 2 Clinical Trial of SPX-101 for the Treatment of Cystic Fibrosis
-
Form 13F-HR Canaan Partners VII LLC For: Sep 30
-
Mynd Secures Additional 5 Million in Funding Led by Lightspeed Ventures
-
Zugata Partners With Skillshare and The Muse to Help Companies Deliver Personalized Professional Development
-
TechCrunch Disrupt San Francisco 2017 Announces Startup Battlefield Competitors
-
ExecThread Raises $6.5 Million to Accelerate Growth of its Crowdsourced Jobs Platform
-
ExecThread Raises $6.5 Million to Accelerate Growth of its Crowdsourced Jobs Platform
-
Aunt Fannie's Closes $2.5 Million Investment Round Led by RCV Partners, CircleUp and Monica Nassif
-
Truveris Secures $25 Million in New Funding to Help Reduce Cost and Improve Access to Prescription Medications
-
Inova Names Mickey Y. Kim, MD, MBA, Senior Vice President of Research and Commercialization
-
Turo Raises $92M Series D, Acquires Daimler's Croove to Continue Global Expansion
-
Mynd Announces Acquisition Of Pacific Shore Management
-
Ollie Raises $12.6M In Series A Funding To Continue To Disrupt Pet Food Space
-
Leanplum's Analysis Reveals Push Notifications Increase In-App Spend 16% and Drive 9.6X More Users to Buy
-
One of Google’s Youngest Hires Raises $16.3 Million From Investors Including Mark Cuban To Revolutionize Information Discovery
-
PerimeterX Raises $23M to Expand AI-Driven Behavioral Threat Protection Platform That Prevents Bot Attacks
-
Form 13F-HR Canaan Partners VII LLC For: Jun 30
-
Aircall Launches Latest Integration with Kustomer CRM for Support Teams
-
Unchained Labs racks up another one, acquires Trinean!
-
Vivace Therapeutics Comes out of Stealth with $40 Million to Turn Novel Biology into First-in-Class Cancer Therapeutics
-
Diabetes Data Platform Leader Glooko Raises $35 Million in Series C
-
Launching the Biden Cancer Initiative
-
FinTech Innovation Lab Celebrates Seventh Anniversary, Entrepreneurs Debut Breakthrough Technologies in Cybersecurity, Artificial Intelligence and Fraud Detection
-
Spyryx Biosciences Expands Development Award with Cystic Fibrosis Foundation; Presents Phase 1 Data for SPX-101 at the European Cystic Fibrosis Conference
-
Spyryx Biosciences to Present at the 2017 BIO International Convention
-
Eiger Announces Appointment of Biopharmaceutical Industry Veteran David Apelian, MD, PhD, MBA to its Board of Directors
-
Hyalex Orthopaedics Raises $16 Million Series A Financing and Appoints Chief Executive Officer
-
Genome Medical Launches Expert Network for Clinical Genetics
-
Spyryx Biosciences Reports Positive Data on SPX-101 at American Thoracic Society International Conference
-
Iterum Secures $65 Million in Series B Financing
-
Arix Bioscience leads $65 million Series B investment round for Iterum
-
Spyryx Biosciences to Present at American Thoracic Society International Conference May 19- 24, 2017, Washington, DC
-
Top Brands Choose Talena: Award-winning Software Reaches Major Data Milestone
-
The American Journal of Respiratory and Critical Care Medicine Publishes Study of Spyryx Biosciences' SPX-101, A Novel ENaC-Targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport
-
Spyryx Biosciences Partners with Cystic Fibrosis Canada, Serves as Presenting Sponsor of the 16th Broken Arrow Conference May 4-6, Toronto, Ontario
-
Dauntless Pharmaceuticals Announces Positive Data from Phase 1 Study Investigating Octreotide Formulation for Intranasal Delivery
-
Leanplum Reveals 120 Power Words That Boost Push Notification Engagement & Conversions
-
Talena Named to CRN's 2017 Big Data 100 List
-
Leanplum Ranked #3 on Bay Area Best Places to Work List
-
Onkos Surgical™ Secures $17.6M in Series B Funding Led by Canaan Partners
-
Golub Capital's Late Stage Lending Group Provides Growth Financing To Switchfly, Inc.
-
Form 13F-HR Canaan Partners VII LLC For: Mar 31
-
Spyryx Biosciences Presents Data and Corporate Update at Two Recent Conferences in Support of Clinical Candidate for Cystic Fibrosis
-
IVP Promotes Roseanne Wincek to Principal
-
CytomX Therapeutics (CTMX) Names Marion McCourt to Board of Directors
-
Spyryx Biosciences to Present at the Needham Healthcare Conference Tuesday, April 4, 2017 New York, N.Y.

